Introducing TBS Reveal* a new AI-driven opportunistic screening software for bone fragility assessment using routine X-rays TBS Reveal* submitted to the FDA under the 510(k) procedure Live at RSNA: ...
GENEVA, Switzerland--(BUSINESS WIRE)--Medimaps Group S.A., a global leader in AI-driven bone microarchitecture imaging solutions, today announced the first live presentations of its new software TBS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback